Press release

Brussels, April 30th, 2014 --- Solvay has obtained a European patent protecting the use of its innovative emana® smart fiber, from the European Patent Office (EPO).


emana® is a Far Infrared (FIR) yarn, polyamide 6.6-based, when in contact to the skin, interacts to the body and improves blood micro-circulation. Several clinical tests show, emana® offers sportswear and cosmetic benefits, as skin elasticity improvement and helps reducing the signs of cellulite.


The EPO granted the patent (EP2402387) after extensive examination, confirming emana®’s truly innovative technology that will benefit and add value to the textile market and its customers.

The granting of the patent is a final confirmation of the innovative Far Infrared technology used in emana®. The patent protects our unique product against reproduction and use by competitors and followers,” said Gabriel Gorescu, Marketing and Innovation Manager of the Fibras Global Business Unit at Solvay. “It also recognizes many years of research and investments that went into this project from its conception until its marketing.”

Follow us on twitter @SolvayGroup  

As an international chemical group, SOLVAY assists industries in finding and implementing ever more responsible and value-creating solutions. Solvay generates 90% of its net sales in activities where it is among the world's top three players. It serves many markets, varying from energy and the environment to automotive and aeronautics or electricity and electronics, with one goal: to raise the performance of its clients and improve society's quality of life. The group is headquartered in Brussels, employs about 29,400 people in 56 countries and generated 9.9 billion euros in net sales in 2013. Solvay SA is listed as SOLB.BE on NYSE Euronext in Brussels and Paris (Bloomberg: SOLB:BB - Reuters: SOLB.BR).